查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1425418

2024 年药品和医疗设备组合全球市场报告

Drug Device Combination Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，药品和医疗设备组合的市场规模迅速扩大。将从2023年的1,203.7亿美元扩大到2024年的1,344.1亿美元，复合年增长率为11.7%。过去观察到的增长是由于医疗创新的增加、慢性病患病率的增加、以患者为中心的方法的采用、生技药品的进步、单一疗法相关的挑战以及医学领域不断变化的临床需求等因素造成的。

由于事故造成的伤亡人数增加，预计医药和医疗设备市场将出现成长。事故通常是不可预测的，并会导致伤害和伤害，但可以透过药物和设备的结合来有效管理和预防。这些组合有助于有针对性的医疗干预并提高事故后患者的安全。 2021年，加拿大报告了1,768起致命机动车事故，比前一年增加了1.3%。药物-设备组合在管理伤亡和提供关键医疗干预方面的作用使其成为事故相关医疗解决方案的重要组成部分，从而促进市场成长。

就 2023 年製药和医疗设备市场占有率而言，北美是最大的地区。预计亚太地区将成为预测期内成长最快的地区。药品和医疗设备组合市场报告涵盖的地区包括亚太地区、西欧、东欧、北美、南美以及中东和非洲。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球药物和医疗设备组合市场的驱动因素和限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023年全球製药和医疗设备组合市场规模表现与成长
  • 2023-2028、2033年全球药品医疗设备组合市场规模及成长预测

第六章市场区隔

  • 全球製药和医疗设备组合市场，按产品细分、绩效和预测，2018-2023、2023-2028、2033
  • 自动注射器
  • 微针贴片
  • 数字药丸
  • 智慧吸入器
  • 药物递送水凝胶
  • 药物释放型镜片
  • 其他的
  • 全球药品和医疗设备组合市场，按分销管道细分、绩效和预测，2018-2023、2023-2028、2033
  • 直接竞标
  • 零售
  • 其他的
  • 全球製药和医疗设备组合市场，按应用细分、绩效和预测，2018-2023、2023-2028、2033
  • 整形外科疾病
  • 呼吸系统疾病
  • 糖尿病
  • 肿瘤学
  • 心血管疾病
  • 其他的
  • 全球药品和医疗设备组合市场，按最终用户细分，实际和预测，2018-2023、2023-2028、2033
  • 诊所
  • 医院
  • 居家医疗
  • 门诊治疗中心
  • 其他的

第 7 章 区域与国家分析

  • 全球药品和医疗设备组合市场，按地区、绩效和预测，2018-2023年、2023-2028年、2033年
  • 全球药品和医疗设备组合市场，依国家、绩效及预测，2018-2023年、2023-2028年、2033年

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 药品/医疗设备组合市场竞争形势
  • 製药和医疗设备组合市场的公司概况
    • The 3M Company
    • Abbott India Ltd.
    • Biotronik SE &Co. KG
    • Boston Scientific Corporation
    • CR Bard Inc

第31章竞争基准化分析

第 32 章竞争对手仪表板

第三十三章 重大併购

第34章 未来前景与潜力分析

第35章附录

简介目录
Product Code: r12649

Drug Device Combination Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug device combination market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug device combination? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug device combination market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Product: Auto-Injector; Microneedle Patch; Digital Pill; Smart Inhaler; Drug Delivery Hydrogels; Drug-Eluting Lens; Other Products
  • 2) By Distribution Channel: Direct Tender; Retails Sales; Other Distribution Channels
  • 3) By Application: Orthopedic Diseases; Respiratory Diseases; Diabetes; Oncology; Cardiovascular Diseases; Other Applications
  • 4) By End User: Clinics; Hospitals; Home Care Settings; Ambulatory Care Centers; Other End Users
  • Companies Mentioned: The 3M Company; Abbott India Ltd.; Biotronik SE & Co. KG; Boston Scientific Corporation; C. R. Bard Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Drug-device combinations refer to therapeutic and diagnostic products that combine a medical device with a drug, facilitating localized drug administration, precise drug targeting, and personalized therapy. These combinations create a unified entity, physically and chemically, packaged together in a single package. Drug-device combinations play a crucial role in clinical development, enabling the delivery of drugs to specific locations in the body.

The primary types of drug-device combination products include auto-injectors, microneedle patches, digital pills, smart inhalers, drug delivery hydrogels, drug-eluting lenses, and other products. These products find applications in various medical fields such as orthopedic diseases, respiratory diseases, diabetes, oncology, cardiovascular diseases, among others. The end users of drug-device combination products include clinics, hospitals, home care settings, ambulatory care centers, and others. These products are distributed through direct tenders, retail sales, and other distribution channels.

The drug-device combination market research report is one of a series of new reports from The Business Research Company that provides drug-device combination market statistics, including drug-device combination industry global market size, regional shares, competitors with an drug-device combination market share, detailed drug-device combination market segments, market trends and opportunities, and any further data you may need to thrive in the drug-device combination industry. This drug-device combination market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug device combination market size has grown rapidly in recent years. It will grow from $120.37 billion in 2023 to $134.41 billion in 2024 at a compound annual growth rate (CAGR) of 11.7%. The growth observed in the historical period can be attributed to factors such as increasing medical innovation, a rise in chronic diseases, the adoption of patient-centric approaches, advances in biologics, challenges associated with monotherapy, and evolving clinical needs in the healthcare sector.

The drug device combination market size is expected to see rapid growth in the next few years. It will grow to $205.86 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%. The anticipated growth in the forecast period can be attributed to factors such as patient empowerment and engagement, the ongoing digitalization of healthcare, global market expansion, the emergence of novel therapies, and the shift towards value-based healthcare models. Major trends in the forecast period encompass advancements in therapeutic approaches, the management of complex diseases, the promotion of patient-centric care, continuous technological innovations, and regulatory support for healthcare initiatives.

The drug-device combination market is witnessing substantial growth driven by the increasing prevalence of chronic diseases. Chronic diseases, persisting for a year or longer and requiring ongoing medical care, include conditions like heart disease and diabetes. Drug-device combinations, encompassing therapeutic and diagnostic products, play a pivotal role in effectively treating individuals with chronic diseases. As per the World Health Organization's report, the global incidence of diabetes surpassed 420 million in 2022, with projections indicating a rise to 578 million by 2030 and 700 million by 2045. This escalating prevalence underscores the critical role of drug-device combinations in managing chronic diseases, thereby propelling the growth of the market.

The drug-device combination market is expected to experience growth propelled by an increase in casualties resulting from accidents. Accidents, often unforeseen and leading to harm or injury, can be effectively managed and prevented through the use of drug-device combinations. These combinations facilitate targeted medical interventions, enhancing patient safety in the aftermath of accidents. In 2021, Canada reported 1,768 motor vehicle fatalities, indicating a 1.3% increase from the previous year. The role of drug-device combinations in managing casualties and providing critical medical interventions positions them as integral components in accident-related healthcare solutions, thereby contributing to the growth of the market.

Technological advancement emerges as a key trend shaping the drug-device combination market. Major corporations are introducing innovative technologies to fortify their market positions. A notable example is Owen Mumford's Aidaptus auto-injector platform, launched in September 2021. This two-stage, spring-powered auto-injector incorporates self-adjusting plunger stopper sensing technology, adapting to various stopper positions and filling levels in prefilled glass syringes. Such advancements enhance the precision and efficiency of drug delivery, showcasing the industry's commitment to leveraging technology for improved healthcare outcomes.

Major companies operating in the drug-device combination market are introducing distinctive products to streamline administration processes. An exemplary launch is the G-Lasta Subcutaneous Injection 3.6 mg BodyPod by Terumo Corporation and Kyowa Kirin. This drug-device combination involves an automated injection device attached during chemotherapy, administering G-Lasta to reduce febrile neutropenia incidence. The automated system eliminates the need for additional outpatient visits, alleviating the burden on patients and exemplifying how innovative drug-device combinations contribute to enhanced treatment protocols and patient care.

In July 2021, BD, a renowned US-based medical device company, successfully acquired Zebrasci for an undisclosed sum. This strategic acquisition is poised to enhance BD's contract development service capabilities, specifically in the areas of testing and validation of combination products. By integrating Zebrasci's expertise, BD aims to strengthen its market position in the field of medical devices. Zebrasci, the acquired company, is a prominent US-based biotechnology firm specializing in the development of combination products.

Major companies operating in the drug device combination market report are The 3M Company, Abbott India Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, C. R. Bard Inc., Medtronic PLC, Amgen Inc., Ypsomed Holding AG, Micron Biomedical Inc., MetP Pharma AG, Sonceboz SA, Propeller Health B.D. Inc., Lepu Medical Technology (Beijing) Co. Ltd., Eitan Medical Ltd., Vaxess Technologies Inc., Subcuject Aps, Allergan PLC, Terumo Corporation, Stryker Corporation, Becton Dickinson and Company, Novartis AG, Zimmer Biomet Holdings Inc., MediPrint Ophthalmics, Arrow International Inc., Alcon Inc., W. L. Gore & Associates Inc., Cook Medical LLC, Pinnacle Biologics Inc., GlaxoSmithKline PLC, and Mylan N.V.

North America was the largest region in the drug-device combination market share in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug device combination market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug device combination market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drug-device combination market consists of sales of catheter and advanced wound care products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Drug Device Combination Market Characteristics

3. Drug Device Combination Market Trends And Strategies

4. Drug Device Combination Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Drug Device Combination Market Size and Growth

  • 5.1. Global Drug Device Combination Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Drug Device Combination Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Drug Device Combination Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Drug Device Combination Market Segmentation

  • 6.1. Global Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Auto-Injector
  • Microneedle Patch
  • Digital Pill
  • Smart Inhaler
  • Drug Delivery Hydrogels
  • Drug-Eluting Lens
  • Other Products
  • 6.2. Global Drug Device Combination Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Direct Tender
  • Retails Sales
  • Other Distribution Channels
  • 6.3. Global Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Orthopedic Diseases
  • Respiratory Diseases
  • Diabetes
  • Oncology
  • Cardiovascular Diseases
  • Other Applications
  • 6.4. Global Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Clinics
  • Hospitals
  • Home Care Settings
  • Ambulatory Care Centers
  • Other End Users

7. Drug Device Combination Market Regional And Country Analysis

  • 7.1. Global Drug Device Combination Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Drug Device Combination Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Drug Device Combination Market

  • 8.1. Asia-Pacific Drug Device Combination Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Drug Device Combination Market

  • 9.1. China Drug Device Combination Market Overview
  • 9.2. China Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Drug Device Combination Market

  • 10.1. India Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Drug Device Combination Market

  • 11.1. Japan Drug Device Combination Market Overview
  • 11.2. Japan Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Drug Device Combination Market

  • 12.1. Australia Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Drug Device Combination Market

  • 13.1. Indonesia Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Drug Device Combination Market

  • 14.1. South Korea Drug Device Combination Market Overview
  • 14.2. South Korea Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Drug Device Combination Market

  • 15.1. Western Europe Drug Device Combination Market Overview
  • 15.2. Western Europe Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Drug Device Combination Market

  • 16.1. UK Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Drug Device Combination Market

  • 17.1. Germany Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Drug Device Combination Market

  • 18.1. France Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Drug Device Combination Market

  • 19.1. Italy Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Drug Device Combination Market

  • 20.1. Spain Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Drug Device Combination Market

  • 21.1. Eastern Europe Drug Device Combination Market Overview
  • 21.2. Eastern Europe Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Drug Device Combination Market

  • 22.1. Russia Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Drug Device Combination Market

  • 23.1. North America Drug Device Combination Market Overview
  • 23.2. North America Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Drug Device Combination Market

  • 24.1. USA Drug Device Combination Market Overview
  • 24.2. USA Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Drug Device Combination Market

  • 25.1. Canada Drug Device Combination Market Overview
  • 25.2. Canada Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Drug Device Combination Market

  • 26.1. South America Drug Device Combination Market Overview
  • 26.2. South America Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Drug Device Combination Market

  • 27.1. Brazil Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Drug Device Combination Market

  • 28.1. Middle East Drug Device Combination Market Overview
  • 28.2. Middle East Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Drug Device Combination Market

  • 29.1. Africa Drug Device Combination Market Overview
  • 29.2. Africa Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Drug Device Combination Market Competitive Landscape And Company Profiles

  • 30.1. Drug Device Combination Market Competitive Landscape
  • 30.2. Drug Device Combination Market Company Profiles
    • 30.2.1. The 3M Company
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Abbott India Ltd.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Biotronik SE & Co. KG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Boston Scientific Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. C. R. Bard Inc
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Drug Device Combination Market Competitive Benchmarking

32. Global Drug Device Combination Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Drug Device Combination Market

34. Drug Device Combination Market Future Outlook and Potential Analysis

  • 34.1 Drug Device Combination Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Drug Device Combination Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Drug Device Combination Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer